Features of prescriptions of antihypertensive therapy in patients with diabetes mellitus type 2: Theory and Practice

Authors

  • I. А. Zupanets
  • Yu. S. Rudyk
  • O. V. Gerasymenko
  • O. D. Ilchenko

DOI:

https://doi.org/10.14739/2310-1210.2014.6.35643

Keywords:

Antihypertensive Agents, Diabetes Mellitus Type 2, Hypertension

Abstract

Frequent association of DM type 2 with hypertension, presence of early complications and progressive course of disease predetermine selection of an individual antihypertensive therapy in this clinical group.

Aim of research was to analyze the practical prescription of drugs in patients with concomitant DM type 2.

Methods and results.We studied 71 case history (35 with hypertension and 36 with hypertension and DM type 2). It has been found that in patients with only hypertension diuretics were prescribed in 89%, beta-blockers - in 69%, ACE inhibitors - in 57%, ARBs - in 31%, calcium - 14%. In patients with hypertension and DM diuretics were prescribed in 78 % of cases, beta-blockers - 70 %, ACE inhibitors - 47 %, ARB - 50 %, calcium - 25 % of cases. Among diuretics the most often hydrochlorothiazide was prescribed, among beta-blockers mostly selective one were prescribed. Combination therapy was given in 89 % of patients with only hypertension and 94 % with hypertension and DM.

Conclusion. Thus, antihypertensive therapy in patients with DM type 2 is generally compliant. Individual therapy optimization is possible with consultation of Clinical pharmacist.

References

Weycker, D., Nichols, G. A., O’Keeffe-Rosetti, M., Edelsberq, J., Vincze, G., Khan, M., & Oster, G. (2009) Excess risk of diabetes in persons with hypertension. J. Diabet. Comlic, 23(5), 330–336. doi: 10.1016/j.jdiacomp.2008.04.002.

Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2010) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract., 87, 311–321. doi: 10.1016/j.diabres.2009.10.007.

Ferrannini, E., & Cushman, W. C. (2012) Diabetes and hypertension: the bad companions. Lancet, 380, 601–610. doi: 10.1016/S0140-6736(12)60987-8.

Jiang, B., Liu, Y., Liu, Y, Fang, F., Wang, X., & Li, B. (2014) Association of four insulin resistance genes with type 2 diabetes mellitus and hypertension in the Chinese Han population. Mol. Biol. Rep., 41, 925–933. doi: 10.1007/s11033-013-2937-0.

Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., et al. (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart. J., 34(28), 2159–2219.

(2011) NICE clinical guideline 127. Hypertension: Clinical management of primary hypertension in adults. British Hypertension Society recommendation Retrieved from www.nice.org.uk/guidance/CG127.

(2012) American Diabetes Association. Executive summary: standards of medical care in diabetes – 2012. Diabetes Care, 35(1), S4-S10. doi: 10.2337/dc12-s004.

Cheng, J., Zhang, W., Zhang, X., Han, F., Li, X., He, X., et al. (2014) Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular death, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. JAMA Intern. Med., 174. doi: 10.1001/jamainternmed.2014.348. doi: 10.1001/jamainternmed.2014.348.

Iwai, M., Li, H.-Sh., Chen, R., Shiuchi, T., Wu, L., Min, L.-J., et al. (2006) Calcium Channel Blocker Azelnidipine Reduces Glucose Intolerance in Diabetic Mice via Different Mechanism than Angiotensin Receptor Blocker Olmesartan. J. Pharmacol. Exp. Ther., 319, 1081–1087.

Makolkin, V. I. (2010) Poziciya beta-adrenoblokatorov i diuretikov v obnovlennykh Europeyskikh recomendaciyakh po arterialnoy hypertenzii (2009) [The position of beta-blockers and diuretics in the updated European Guidelines on Hypertension (2009)]. Lechashchiy vrach, 7. Retrieved from http://www.lvrach.ru/2010/07/15063169. [in Russian].

Downloads

How to Cite

1.
Zupanets IА, Rudyk YS, Gerasymenko OV, Ilchenko OD. Features of prescriptions of antihypertensive therapy in patients with diabetes mellitus type 2: Theory and Practice. Zaporozhye Medical Journal [Internet]. 2014Dec.8 [cited 2024Nov.23];16(6). Available from: http://zmj.zsmu.edu.ua/article/view/35643

Issue

No. 6 (2014): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)